| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 4.61e-11 | 5 | 173 | 5 | GO:0004556 | |
| GeneOntologyMolecularFunction | amylase activity | 2.75e-10 | 6 | 173 | 5 | GO:0016160 | |
| GeneOntologyMolecularFunction | chloride ion binding | 1.86e-07 | 16 | 173 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 3.20e-05 | 103 | 173 | 7 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 3.74e-05 | 144 | 173 | 8 | GO:0016798 | |
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 5.97e-05 | 25 | 173 | 4 | GO:0017056 | |
| GeneOntologyMolecularFunction | acetate ester transmembrane transporter activity | 4.43e-04 | 4 | 173 | 2 | GO:1901375 | |
| GeneOntologyMolecularFunction | acetylcholine transmembrane transporter activity | 4.43e-04 | 4 | 173 | 2 | GO:0005277 | |
| GeneOntologyMolecularFunction | ISG15 transferase activity | 4.43e-04 | 4 | 173 | 2 | GO:0042296 | |
| GeneOntologyBiologicalProcess | protein localization to cell periphery | NPTX1 ABI3 RHBDF2 CAMK2A LAMA5 ACTN2 PTCH1 EHD4 MISP NKD2 PIK3R2 ARHGAP44 SEC16A ATP1B1 | 1.28e-05 | 422 | 172 | 14 | GO:1990778 |
| GeneOntologyBiologicalProcess | protein localization to plasma membrane | ABI3 RHBDF2 CAMK2A LAMA5 ACTN2 PTCH1 EHD4 NKD2 PIK3R2 ARHGAP44 SEC16A ATP1B1 | 1.85e-05 | 324 | 172 | 12 | GO:0072659 |
| GeneOntologyCellularComponent | multivesicular body lumen | 1.90e-05 | 7 | 173 | 3 | GO:0097486 | |
| GeneOntologyCellularComponent | late endosome lumen | 8.75e-05 | 11 | 173 | 3 | GO:0031906 | |
| GeneOntologyCellularComponent | nuclear membrane | TENT4A NUP62 RETSAT POM121C ATP1B4 NUP210 TM7SF2 UGT2B15 UGT2B17 TMPO CENPV | 1.63e-04 | 349 | 173 | 11 | GO:0031965 |
| GeneOntologyCellularComponent | Golgi lumen | 2.95e-04 | 109 | 173 | 6 | GO:0005796 | |
| Domain | Alpha_amylase | 5.87e-09 | 4 | 165 | 4 | IPR006046 | |
| Domain | Aamy_C | 5.87e-09 | 4 | 165 | 4 | SM00632 | |
| Domain | Alpha-amylase_C | 2.92e-08 | 5 | 165 | 4 | PF02806 | |
| Domain | A-amylase/branching_C | 2.92e-08 | 5 | 165 | 4 | IPR006048 | |
| Domain | Glyco_hydro_13_cat_dom | 2.01e-07 | 7 | 165 | 4 | IPR006047 | |
| Domain | Alpha-amylase | 2.01e-07 | 7 | 165 | 4 | PF00128 | |
| Domain | Aamy | 2.01e-07 | 7 | 165 | 4 | SM00642 | |
| Domain | A-amylase_C | 6.77e-07 | 3 | 165 | 3 | IPR031319 | |
| Domain | Glyco_hydro_b | 7.43e-06 | 15 | 165 | 4 | IPR013780 | |
| Domain | Glyco_hydro_13 | 1.33e-05 | 6 | 165 | 3 | IPR015902 | |
| Domain | Glyco_hydro_catalytic_dom | 2.01e-05 | 38 | 165 | 5 | IPR013781 | |
| Domain | Aspartic_peptidase_N | 2.31e-05 | 7 | 165 | 3 | IPR012848 | |
| Domain | A1_Propeptide | 2.31e-05 | 7 | 165 | 3 | PF07966 | |
| Domain | Aspartic_peptidase_A1 | 7.76e-05 | 10 | 165 | 3 | IPR001461 | |
| Domain | PEPTIDASE_A1 | 7.76e-05 | 10 | 165 | 3 | IPR033121 | |
| Domain | Asp | 7.76e-05 | 10 | 165 | 3 | PF00026 | |
| Domain | PEPTIDASE_A1 | 7.76e-05 | 10 | 165 | 3 | PS51767 | |
| Domain | Glycoside_hydrolase_SF | 1.03e-04 | 53 | 165 | 5 | IPR017853 | |
| Domain | - | 1.40e-04 | 12 | 165 | 3 | 2.40.70.10 | |
| Domain | C8 | 1.40e-04 | 12 | 165 | 3 | PF08742 | |
| Domain | TIL | 1.40e-04 | 12 | 165 | 3 | PF01826 | |
| Domain | ASP_PROTEASE | 1.40e-04 | 12 | 165 | 3 | PS00141 | |
| Domain | Laminin_G | 1.59e-04 | 58 | 165 | 5 | IPR001791 | |
| Domain | Unchr_dom_Cys-rich | 1.81e-04 | 13 | 165 | 3 | IPR014853 | |
| Domain | Aspartic_peptidase_AS | 1.81e-04 | 13 | 165 | 3 | IPR001969 | |
| Domain | C8 | 1.81e-04 | 13 | 165 | 3 | SM00832 | |
| Domain | TIL_dom | 2.29e-04 | 14 | 165 | 3 | IPR002919 | |
| Domain | - | 2.29e-04 | 14 | 165 | 3 | 2.60.40.1180 | |
| Domain | - | 2.48e-04 | 35 | 165 | 4 | 3.20.20.80 | |
| Domain | VWF_type-D | 3.48e-04 | 16 | 165 | 3 | IPR001846 | |
| Domain | VWFD | 3.48e-04 | 16 | 165 | 3 | PS51233 | |
| Domain | VWD | 3.48e-04 | 16 | 165 | 3 | SM00216 | |
| Domain | VWD | 3.48e-04 | 16 | 165 | 3 | PF00094 | |
| Domain | Peptidase_aspartic_dom | 4.20e-04 | 17 | 165 | 3 | IPR021109 | |
| Domain | ATPASE_NA_K_BETA_2 | 4.60e-04 | 4 | 165 | 2 | PS00391 | |
| Domain | CTCK_1 | 5.01e-04 | 18 | 165 | 3 | PS01185 | |
| Domain | VWC_out | 5.91e-04 | 19 | 165 | 3 | SM00215 | |
| Domain | LamG | 6.05e-04 | 44 | 165 | 4 | SM00282 | |
| Domain | Na/K_ATPase_sub_beta | 7.62e-04 | 5 | 165 | 2 | IPR000402 | |
| Domain | Na_K-ATPase | 7.62e-04 | 5 | 165 | 2 | PF00287 | |
| Domain | ATPASE_NA_K_BETA_1 | 7.62e-04 | 5 | 165 | 2 | PS00390 | |
| Domain | CT | 9.22e-04 | 22 | 165 | 3 | SM00041 | |
| Domain | WxxW_domain | 1.14e-03 | 6 | 165 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 1.14e-03 | 6 | 165 | 2 | PF13330 | |
| Domain | Cys_knot_C | 1.35e-03 | 25 | 165 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.35e-03 | 25 | 165 | 3 | PS01225 | |
| Domain | - | 1.55e-03 | 95 | 165 | 5 | 2.60.120.200 | |
| Domain | GPX_AS | 1.58e-03 | 7 | 165 | 2 | IPR029759 | |
| Domain | GLUTATHIONE_PEROXID_2 | 2.10e-03 | 8 | 165 | 2 | PS00763 | |
| Domain | GLUTATHIONE_PEROXID_1 | 2.10e-03 | 8 | 165 | 2 | PS00460 | |
| Domain | Glutathione_peroxidase | 2.10e-03 | 8 | 165 | 2 | IPR000889 | |
| Domain | GLUTATHIONE_PEROXID_3 | 2.10e-03 | 8 | 165 | 2 | PS51355 | |
| Domain | GPX_CS | 2.10e-03 | 8 | 165 | 2 | IPR029760 | |
| Domain | GSHPx | 2.10e-03 | 8 | 165 | 2 | PF00255 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 1.22e-08 | 9 | 143 | 5 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 4.41e-08 | 11 | 143 | 5 | M1091 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 8.72e-07 | 52 | 143 | 7 | M14171 | |
| Pathway | REACTOME_DIGESTION | 2.91e-06 | 23 | 143 | 5 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 8.16e-06 | 28 | 143 | 5 | M27837 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 5.51e-05 | 8 | 143 | 3 | MM14717 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 1.03e-04 | 74 | 143 | 6 | M48006 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.33e-04 | 49 | 143 | 5 | MM14837 | |
| Pathway | BIOCARTA_NPC_PATHWAY | 1.59e-04 | 11 | 143 | 3 | M22033 | |
| Pathway | WP_GASTRIC_ACID_PRODUCTION | 1.59e-04 | 11 | 143 | 3 | M39726 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 1.94e-04 | 53 | 143 | 5 | M27212 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 2.93e-04 | 32 | 143 | 4 | M29579 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3 | 2.93e-04 | 32 | 143 | 4 | M40041 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 3.31e-04 | 33 | 143 | 4 | M27016 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 3.72e-04 | 34 | 143 | 4 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 4.16e-04 | 35 | 143 | 4 | M27320 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.65e-04 | 36 | 143 | 4 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.65e-04 | 36 | 143 | 4 | M27245 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 5.17e-04 | 37 | 143 | 4 | M27038 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 5.17e-04 | 37 | 143 | 4 | M1029 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 5.58e-04 | 140 | 143 | 7 | M587 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 5.64e-04 | 101 | 143 | 6 | M27253 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 6.34e-04 | 39 | 143 | 4 | M27238 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 6.99e-04 | 40 | 143 | 4 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 7.68e-04 | 41 | 143 | 4 | MM15200 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 7.68e-04 | 41 | 143 | 4 | M29574 | |
| Pubmed | 1.72e-11 | 6 | 173 | 5 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 1.72e-11 | 6 | 173 | 5 | 2788608 | |
| Pubmed | 1.72e-11 | 6 | 173 | 5 | 15286789 | ||
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 1.72e-11 | 6 | 173 | 5 | 6608795 | |
| Pubmed | 1.72e-11 | 6 | 173 | 5 | 2081604 | ||
| Pubmed | 5.99e-11 | 7 | 173 | 5 | 7949740 | ||
| Pubmed | 1.59e-10 | 8 | 173 | 5 | 12414807 | ||
| Pubmed | 2.45e-10 | 18 | 173 | 6 | 34446743 | ||
| Pubmed | 2.45e-10 | 18 | 173 | 6 | 36057966 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 5.91e-10 | 4 | 173 | 4 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 5.91e-10 | 4 | 173 | 4 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 5.91e-10 | 4 | 173 | 4 | 6166922 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 5.91e-10 | 4 | 173 | 4 | 26098870 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 5.91e-10 | 4 | 173 | 4 | 4745489 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 5.91e-10 | 4 | 173 | 4 | 94264 | |
| Pubmed | 5.91e-10 | 4 | 173 | 4 | 3872721 | ||
| Pubmed | 5.91e-10 | 4 | 173 | 4 | 2476716 | ||
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 5.91e-10 | 4 | 173 | 4 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 5.91e-10 | 4 | 173 | 4 | 6163812 | |
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 5.91e-10 | 4 | 173 | 4 | 2987507 | |
| Pubmed | 5.91e-10 | 4 | 173 | 4 | 6091898 | ||
| Pubmed | 5.91e-10 | 4 | 173 | 4 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 5.91e-10 | 4 | 173 | 4 | 6162108 | |
| Pubmed | 5.91e-10 | 4 | 173 | 4 | 16152770 | ||
| Pubmed | 5.91e-10 | 4 | 173 | 4 | 2423416 | ||
| Pubmed | 5.91e-10 | 4 | 173 | 4 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 5.91e-10 | 4 | 173 | 4 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 5.91e-10 | 4 | 173 | 4 | 2989529 | |
| Pubmed | 5.91e-10 | 4 | 173 | 4 | 6160849 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 5.91e-10 | 4 | 173 | 4 | 1141004 | |
| Pubmed | 5.91e-10 | 4 | 173 | 4 | 6157477 | ||
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 5.91e-10 | 4 | 173 | 4 | 2431276 | |
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 5.91e-10 | 4 | 173 | 4 | 6207174 | |
| Pubmed | 5.91e-10 | 4 | 173 | 4 | 2410924 | ||
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 5.91e-10 | 4 | 173 | 4 | 2332419 | |
| Pubmed | 7.10e-10 | 10 | 173 | 5 | 2897103 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | TRHDE PGA4 AMY1A AMY1B AMY1C AMY2A AMY2B COL15A1 GPX3 LAMA5 MUC5B ACTN2 IDH1 PGA5 EHD4 NEDD4 KL TPP1 CLN5 PATJ ATP1B1 PGA3 CRB2 MASP2 | 8.03e-10 | 1070 | 173 | 24 | 23533145 |
| Pubmed | 1.30e-09 | 11 | 173 | 5 | 2565740 | ||
| Pubmed | 2.95e-09 | 5 | 173 | 4 | 6529441 | ||
| Pubmed | 2.95e-09 | 5 | 173 | 4 | 6176569 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 2.95e-09 | 5 | 173 | 4 | 34276419 | |
| Pubmed | 2.95e-09 | 5 | 173 | 4 | 1348427 | ||
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 2.95e-09 | 5 | 173 | 4 | 8661735 | |
| Pubmed | 3.77e-09 | 27 | 173 | 6 | 8390965 | ||
| Pubmed | 5.55e-09 | 14 | 173 | 5 | 2902233 | ||
| Pubmed | Combined activities of hedgehog signaling inhibitors regulate pancreas development. | 8.29e-09 | 15 | 173 | 5 | 12917290 | |
| Pubmed | 8.80e-09 | 6 | 173 | 4 | 2002257 | ||
| Pubmed | 8.80e-09 | 6 | 173 | 4 | 2450406 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 8.80e-09 | 6 | 173 | 4 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 8.80e-09 | 6 | 173 | 4 | 284003 | |
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 8.80e-09 | 6 | 173 | 4 | 9250879 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 8.80e-09 | 6 | 173 | 4 | 7859283 | |
| Pubmed | 8.80e-09 | 6 | 173 | 4 | 7946325 | ||
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 8.80e-09 | 6 | 173 | 4 | 1021597 | |
| Pubmed | 1.20e-08 | 16 | 173 | 5 | 2571572 | ||
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 2.05e-08 | 7 | 173 | 4 | 1401878 | |
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 2.05e-08 | 7 | 173 | 4 | 2451911 | |
| Pubmed | 2.05e-08 | 7 | 173 | 4 | 6160178 | ||
| Pubmed | 2.05e-08 | 7 | 173 | 4 | 8604219 | ||
| Pubmed | 2.05e-08 | 7 | 173 | 4 | 8666240 | ||
| Pubmed | 2.05e-08 | 7 | 173 | 4 | 8034329 | ||
| Pubmed | 4.08e-08 | 8 | 173 | 4 | 2040456 | ||
| Pubmed | 4.08e-08 | 8 | 173 | 4 | 3038891 | ||
| Pubmed | 4.08e-08 | 8 | 173 | 4 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 4.08e-08 | 8 | 173 | 4 | 7523515 | |
| Pubmed | 4.08e-08 | 8 | 173 | 4 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 4.08e-08 | 8 | 173 | 4 | 6200103 | |
| Pubmed | 7.31e-08 | 9 | 173 | 4 | 93520 | ||
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 32697825 | ||
| Pubmed | The structure of two distinct pancreatic amylase genes in mouse strain YBR. | 1.21e-07 | 3 | 173 | 3 | 2413838 | |
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 7926498 | ||
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 6176528 | ||
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 9561228 | ||
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 21455714 | ||
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 19800305 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 1.21e-07 | 3 | 173 | 3 | 21827821 | |
| Pubmed | Report of the Committee on the Genetic Constitution of Chromosome 1. | 1.21e-07 | 3 | 173 | 3 | 6360562 | |
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 24170207 | ||
| Pubmed | Tissue-specific and insulin-dependent expression of a pancreatic amylase gene in transgenic mice. | 1.21e-07 | 3 | 173 | 3 | 2436036 | |
| Pubmed | Relationships between the human pepsinogen DNA and protein polymorphisms. | 1.21e-07 | 3 | 173 | 3 | 3014868 | |
| Pubmed | Two distinct pancreatic amylase genes are active in YBR mice. | 1.21e-07 | 3 | 173 | 3 | 6180955 | |
| Pubmed | The ratio of pepsinogen A to pepsinogen C: a sensitive test for atrophic gastritis. | 1.21e-07 | 3 | 173 | 3 | 2799289 | |
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 19872561 | ||
| Pubmed | Comparative genomic analysis of the mouse and rat amylase multigene family. | 1.21e-07 | 3 | 173 | 3 | 17223109 | |
| Pubmed | Human pepsinogen A (PGA): an informative gene complex located at 11q13. | 1.21e-07 | 3 | 173 | 3 | 1968039 | |
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 15299664 | ||
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 8053437 | ||
| Pubmed | Family and population studies on the human pepsinogen A multigene family. | 1.21e-07 | 3 | 173 | 3 | 2566575 | |
| Pubmed | Immunoblot technique to visualise serum pepsinogen A isozymogen patterns. | 1.21e-07 | 3 | 173 | 3 | 2229438 | |
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 25314140 | ||
| Pubmed | Validation of the pepsinogen test method for gastric cancer screening using a follow-up study. | 1.21e-07 | 3 | 173 | 3 | 19890696 | |
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 8413315 | ||
| Pubmed | Diagnostic value of serum pepsinogen C in patients with raised serum concentrations of pepsinogen A. | 1.21e-07 | 3 | 173 | 3 | 8244094 | |
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 21407214 | ||
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 6774973 | ||
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 6300126 | ||
| Pubmed | Pepsinogen I/II ratio is related to glucose, triacylglycerol, and uric acid levels. | 1.21e-07 | 3 | 173 | 3 | 22304859 | |
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 24004680 | ||
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 8038355 | ||
| Pubmed | 1.21e-07 | 3 | 173 | 3 | 22063648 | ||
| Interaction | MKNK1 interactions | 1.26e-07 | 70 | 169 | 8 | int:MKNK1 | |
| Cytoband | 1p21 | 2.88e-08 | 24 | 173 | 5 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 5.59e-05 | 107 | 173 | 5 | chr1p21 | |
| Cytoband | 11q12.2 | 4.35e-04 | 39 | 173 | 3 | 11q12.2 | |
| GeneFamily | CD molecules|Mucins | 2.28e-04 | 21 | 104 | 3 | 648 | |
| GeneFamily | Collagens|Collagen proteoglycans | 3.24e-04 | 5 | 104 | 2 | 575 | |
| GeneFamily | ADAMTS like | 6.75e-04 | 7 | 104 | 2 | 947 | |
| GeneFamily | Nucleoporins | 8.12e-04 | 32 | 104 | 3 | 1051 | |
| GeneFamily | PDZ domain containing|Crumbs complex | 1.15e-03 | 9 | 104 | 2 | 1223 | |
| GeneFamily | Ubiquitin conjugating enzymes E2 | 1.68e-03 | 41 | 104 | 3 | 102 | |
| GeneFamily | Collagens | 2.35e-03 | 46 | 104 | 3 | 490 | |
| GeneFamily | Rhomboid family | 2.85e-03 | 14 | 104 | 2 | 926 | |
| Coexpression | GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN | BCAT1 DNAJC7 TM7SF2 TMPO DNAI4 THNSL2 STARD3NL ATP1B1 RPL3L RAD54L | 9.23e-07 | 200 | 173 | 10 | M4560 |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4 | AMY1B AMY1C AMY2A AMY2B GALM PDK1 IDH1 MSI2 COQ8A UGT2B15 UGT2B17 | 1.31e-05 | 330 | 173 | 11 | MM1120 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | NPTX1 RPS6KA4 GALNT2 MEX3D CXXC5 LAMA5 PCDH20 PPP1R8 MISP NFATC3 NUP210 SEC16A TM7SF2 TMPO SLFN11 STARD3NL MUC5AC MTARC1 | 1.32e-05 | 845 | 173 | 18 | M18090 |
| Coexpression | LEIN_MIDBRAIN_MARKERS | 2.62e-05 | 88 | 173 | 6 | MM717 | |
| Coexpression | HOFFMAN_CLOCK_TARGETS_UP | 3.28e-05 | 10 | 173 | 3 | M2063 | |
| Coexpression | BERGER_MBD2_TARGETS | 4.48e-05 | 11 | 173 | 3 | MM905 | |
| Coexpression | MCCLUNG_CREB1_TARGETS_DN | 4.81e-05 | 60 | 173 | 5 | MM654 | |
| Coexpression | GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN | 5.76e-05 | 200 | 173 | 8 | M4656 | |
| Coexpression | GSE17721_LPS_VS_CPG_4H_BMDC_UP | 5.76e-05 | 200 | 173 | 8 | M3995 | |
| Coexpression | GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP | 5.76e-05 | 200 | 173 | 8 | M5630 | |
| Coexpression | MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8 | 5.95e-05 | 12 | 173 | 3 | M5304 | |
| ToppCell | AT1-AT2_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.56e-08 | 172 | 173 | 9 | 0be41df5d35d818deb7316ac21c9366eb4b7bfd1 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 184 | 173 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 184 | 173 | 8 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 184 | 173 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 184 | 173 | 8 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 184 | 173 | 8 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.39e-07 | 184 | 173 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-07 | 188 | 173 | 8 | bc089cd73d283ed7d2ecbb3936673b4edc89f666 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.51e-07 | 188 | 173 | 8 | eec3d353e51358db4c7621265ee0fdd4298e5b0e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.82e-07 | 189 | 173 | 8 | 977a813e5d7a5a561c1fced2bbf21c20056b88d8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.13e-07 | 190 | 173 | 8 | e252e925600e6457fa6e362a55217f4cffa75cdb | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.89e-07 | 195 | 173 | 8 | a38d9dc6192aea673d96fda6b25e81223fda3abf | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 196 | 173 | 8 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-06 | 196 | 173 | 8 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | Parenchyma_Control_(B.)|World / Sample group, Lineage and Cell type | 1.20e-06 | 200 | 173 | 8 | 220b6e5f936b3d08b031d6cabc5793213b98b8e2 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 160 | 173 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.13e-06 | 160 | 173 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Epithelial-basal_bladder_epithelial_cell_(Krt5+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-06 | 165 | 173 | 7 | 936581de8fcd097401707438b9bbe89dd4e3e247 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-06 | 171 | 173 | 7 | d0ac50071a3854d02113c455fcc940a6ec59bbb9 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-06 | 171 | 173 | 7 | fbf8e9db00573adcada4b25730e191417b7c9999 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-06 | 171 | 173 | 7 | 686f95892c3909973c66c9a27159a070a068f175 | |
| ToppCell | PND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-06 | 171 | 173 | 7 | f7ba03e7bdb687f93782c936c7b3374cc5b3b77c | |
| ToppCell | facs-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.09e-06 | 177 | 173 | 7 | 7f58286fc8797e9bdcf8ece0849f55680905955d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-06 | 177 | 173 | 7 | dc846d0feb94d4c289553cc3ac9dac81d10409cb | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-06 | 177 | 173 | 7 | c9e8149639551a4c8daa90fcb2b895fdcff2e2ba | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.55e-06 | 179 | 173 | 7 | 666072c0e8448dbaec1683d18368ec2502453f90 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-06 | 185 | 173 | 7 | 3e3217c99719fd1d2fa94e16be7712a7e5077152 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.13e-06 | 185 | 173 | 7 | 0ff4148b4701003d9d594e0da8261176fb13aa59 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.42e-06 | 186 | 173 | 7 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.72e-06 | 187 | 173 | 7 | 236e9857729670e87eed30fad58f49e1f56e4a85 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.02e-06 | 188 | 173 | 7 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | COVID-19-lung-Secretory|lung / Disease (COVID-19 only), tissue and cell type | 9.34e-06 | 189 | 173 | 7 | 84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.67e-06 | 190 | 173 | 7 | 20106e5213f6a7560554b8b4f84b23c5554ba975 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.67e-06 | 190 | 173 | 7 | 877b544decf302e0d41be23dffa1861f79c70914 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_myocytic-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 9.67e-06 | 190 | 173 | 7 | 81f8f2cddf4c51b879f315260cd1fca80355a371 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 9.67e-06 | 190 | 173 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.00e-05 | 191 | 173 | 7 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.03e-05 | 192 | 173 | 7 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Degenerative_Distal_Convoluted_Tubule_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.03e-05 | 192 | 173 | 7 | 46ea8f4f292db70420b378c6fa3e55e99413679c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.07e-05 | 193 | 173 | 7 | d994b2f2707877288f88cab7cd6002ef91962c50 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-05 | 194 | 173 | 7 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 1.11e-05 | 194 | 173 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 195 | 173 | 7 | 60d08fb27469d1e247bc47b651d7023ba82cf92f | |
| ToppCell | Bronchial_Brush-Epithelial|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.22e-05 | 197 | 173 | 7 | 272c7f4e582ef57564450540242b0db766b78328 | |
| ToppCell | LAM-Myeloid-Macrophage|Myeloid / Condition, Lineage and Cell class | 1.22e-05 | 197 | 173 | 7 | 355fe286609df2ded973952f1856bbc5f437cfd0 | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 1.26e-05 | 198 | 173 | 7 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-05 | 199 | 173 | 7 | fb9550bbb1fa206c3132e0a21a646eedb41c281a | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-goblet|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-05 | 199 | 173 | 7 | 440f47e320c75f49ef47139b46962de68cee8320 | |
| ToppCell | PSB-critical-LOC-Epithelial|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.31e-05 | 199 | 173 | 7 | 58dcb0eedafa8629585dc99e53147e2287f49689 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.78e-05 | 151 | 173 | 6 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-05 | 153 | 173 | 6 | 9f0607a88d5f8a2c128a2ff64dfbc986212f13b2 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.11e-05 | 154 | 173 | 6 | ec56b7fb88e39041416c384f371c767f3b4e92fa | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.72e-05 | 159 | 173 | 6 | e6ff9d2bce62bf9ea173af80b688eeb40fa4ea4c | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-05 | 161 | 173 | 6 | 133b4fadb499e842c19f573f9cf09ce08c1d4813 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-05 | 161 | 173 | 6 | 9466b8658244116f8d21f2f88fb8c2d184b1bdf2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.99e-05 | 161 | 173 | 6 | cb177ca10d848d0e25399ab5ebfcde1071fb94c2 | |
| ToppCell | PND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.13e-05 | 162 | 173 | 6 | 96c6e94a10b124a1d25dcd705ec5aaa8609c1089 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.27e-05 | 163 | 173 | 6 | b589ff57d58dcb215ee3b5a10d81f43e5752a196 | |
| ToppCell | Healthy_Control-Lymphoid-Plasma|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 4.27e-05 | 163 | 173 | 6 | 2913ccdd4613472cd82077d4993e1d9f8b223398 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.73e-05 | 166 | 173 | 6 | c20479fe7a4306320d7f26e78bf956225f00f35a | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 168 | 173 | 6 | e156297a7515e785a9e79a9676700bd3a9d92b98 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.05e-05 | 168 | 173 | 6 | 32e0bc0873baa13027241063283ef26d2aab56f5 | |
| ToppCell | Control-Epithelial_cells-ECM-high_epithelial|Control / group, cell type (main and fine annotations) | 5.40e-05 | 170 | 173 | 6 | e2023d66e70983c87dacbd6181d3426488d1fc57 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-monocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.58e-05 | 171 | 173 | 6 | 992df143d76f9e7fb1997a8996f61e941f0f9d4f | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.95e-05 | 173 | 173 | 6 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.95e-05 | 173 | 173 | 6 | c3762655caa79ac4879876f470d32578a3c93b01 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_B-B_plasma-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.14e-05 | 174 | 173 | 6 | bdbaf805a94b2f5a0065933dab6bf84e3cabd525 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 6.34e-05 | 175 | 173 | 6 | 7de1023161233b64f11e130881c742f4cf2bff65 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.34e-05 | 175 | 173 | 6 | dc7721794162dee96944f4b4b87b5681bb02ea8f | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-05 | 176 | 173 | 6 | 606704098bfdf8bfef740a3544a372fae1e75969 | |
| ToppCell | droplet-Lung-LUNG-30m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.54e-05 | 176 | 173 | 6 | acb9e29773030f6452a069f8f7e53eab68ab7bd3 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Parm1-Excitatory_Neuron.Slc17a7.Parm1.Ndnf_(Deep_layer_pyramidal_cells--layer_5)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.63e-05 | 56 | 173 | 4 | 64ccf87f1baf014924dd42a4eb5e7a3e99b365dd | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 173 | 6 | 692cd03bf0958ebeec34d41bfe87713a768e9a8e | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 173 | 6 | 9c7c6824b9011363851f084a500d665f025b026e | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 173 | 6 | c08583ea68bbeb6b5de852a46b0c0f04792dae55 | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.75e-05 | 177 | 173 | 6 | 2bf639e9e801e5144462ffc957f5739e0dfcd500 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 6.96e-05 | 178 | 173 | 6 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 179 | 173 | 6 | dcaf2191134a586d50ebaf67dcf5b815b54a722b | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 179 | 173 | 6 | 7d61466181ab73088de3ec8a129d7cfa8cac7ecc | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 179 | 173 | 6 | 6c98ce32cb55cf9cee557449e41b23bdb22f5efd | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 179 | 173 | 6 | 87a69f9f83b8f0c028a4874acb238f2e079bf51f | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-05 | 179 | 173 | 6 | f99500c4a590e5152ded5862690f7fa614d64a80 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.41e-05 | 180 | 173 | 6 | 755050226eeb1991ee7f0d15e39d0458f3e4a791 | |
| ToppCell | facs-Pancreas-Exocrine-24m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 180 | 173 | 6 | 72310baeed848f2c483ae986cd73d2fb2cca7feb | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_proximal_straight_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 180 | 173 | 6 | b34d933cdabf692f02eaaf65c2aaca1fb9510627 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.41e-05 | 180 | 173 | 6 | b509c7d6bdfba672065fb722874bdc68de72ba1c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.41e-05 | 180 | 173 | 6 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | droplet-Kidney|droplet / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-05 | 180 | 173 | 6 | 7e5f497699876ac8e1ce780626c6f5a1f6f5f079 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-Ciliated|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.64e-05 | 181 | 173 | 6 | 8eed9d46d924b16f6dd1a025ff612244b02b4391 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 7.64e-05 | 181 | 173 | 6 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.64e-05 | 181 | 173 | 6 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.64e-05 | 181 | 173 | 6 | 576da14ab3107f89e1f44a4a439d1bef5bb42370 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-05 | 182 | 173 | 6 | bdeebbfffc1308a29b721a5f8fed23a28d7a2f2f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.87e-05 | 182 | 173 | 6 | eb138aa1dca9373f1586600f258df06dcf56d81f | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-05 | 182 | 173 | 6 | faf0dfa3adc2d2706b6942b5127093ccdc856447 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Epcam____kidney_proximal_convoluted_tubule_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.87e-05 | 182 | 173 | 6 | be8dd52898525ce6632af0adc2801944f3ac10bd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-05 | 183 | 173 | 6 | b5ede5a0048c585b73c00e88aeddbcaf669347b1 | |
| ToppCell | COVID-19-lung-AT1|lung / Disease (COVID-19 only), tissue and cell type | 8.11e-05 | 183 | 173 | 6 | 942530449e9c6583705eeb8f6f12621daea57252 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 8.11e-05 | 183 | 173 | 6 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.11e-05 | 183 | 173 | 6 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| Drug | FG5P | 7.36e-11 | 11 | 171 | 6 | CID000127486 | |
| Drug | R 623 | 1.34e-10 | 6 | 171 | 5 | CID003027594 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 1.34e-10 | 6 | 171 | 5 | CID003083414 | |
| Drug | dimethylaminomethylferrocene | 1.34e-10 | 6 | 171 | 5 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 1.34e-10 | 6 | 171 | 5 | CID000127364 | |
| Drug | CNP-G3 | 1.34e-10 | 6 | 171 | 5 | CID003082910 | |
| Drug | AC1L5BOU | 4.68e-10 | 7 | 171 | 5 | CID000174858 | |
| Drug | BG5P | 4.68e-10 | 7 | 171 | 5 | CID003082752 | |
| Drug | desethylaprophen | 1.24e-09 | 8 | 171 | 5 | CID000163919 | |
| Drug | azintamide | 1.24e-09 | 8 | 171 | 5 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 2.77e-09 | 9 | 171 | 5 | CID000194237 | |
| Drug | trestatin A | 2.77e-09 | 9 | 171 | 5 | CID003054994 | |
| Drug | P664 | 2.83e-09 | 18 | 171 | 6 | CID000107429 | |
| Drug | N-PMT | 3.07e-09 | 4 | 171 | 4 | CID000194224 | |
| Drug | AC1MQT4V | 3.07e-09 | 4 | 171 | 4 | CID003482066 | |
| Drug | SAIB-SG | 3.07e-09 | 4 | 171 | 4 | CID002735139 | |
| Drug | 2-nitropropyl acetate | 3.07e-09 | 4 | 171 | 4 | CID013573844 | |
| Drug | Dembrexine | 3.07e-09 | 4 | 171 | 4 | CID000072009 | |
| Drug | g lw | 3.07e-09 | 4 | 171 | 4 | CID000444139 | |
| Drug | beta-santalene | 3.07e-09 | 4 | 171 | 4 | CID000010534 | |
| Drug | AC1LAC07 | 5.51e-09 | 10 | 171 | 5 | CID000485275 | |
| Drug | Glc)4 | 5.51e-09 | 10 | 171 | 5 | CID000189098 | |
| Drug | Ro 20-0083 | 5.51e-09 | 10 | 171 | 5 | CID003082332 | |
| Drug | AC1L3M0Q | 5.51e-09 | 10 | 171 | 5 | CID000118008 | |
| Drug | validamycin D | 1.00e-08 | 11 | 171 | 5 | CID000166726 | |
| Drug | CNP-G5 | 1.00e-08 | 11 | 171 | 5 | CID000127309 | |
| Drug | HgI2 | 1.00e-08 | 11 | 171 | 5 | CID000024485 | |
| Drug | 2C KM | 1.00e-08 | 11 | 171 | 5 | CID009549196 | |
| Drug | Deposiston | 1.53e-08 | 5 | 171 | 4 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 1.53e-08 | 5 | 171 | 4 | CID010358258 | |
| Drug | lunularic acid | 1.53e-08 | 5 | 171 | 4 | CID000161413 | |
| Drug | himachalene | 1.53e-08 | 5 | 171 | 4 | CID000015095 | |
| Drug | actinidine | 1.53e-08 | 5 | 171 | 4 | CID000068231 | |
| Drug | 2TAA | 1.53e-08 | 5 | 171 | 4 | CID000127374 | |
| Drug | cimicifugic acid A | 1.53e-08 | 5 | 171 | 4 | CID006449879 | |
| Drug | silver perchlorate | 1.53e-08 | 5 | 171 | 4 | CID000024562 | |
| Drug | AC1L4DZ4 | 1.53e-08 | 5 | 171 | 4 | CID000155287 | |
| Drug | azaprophen | 1.71e-08 | 12 | 171 | 5 | CID000129486 | |
| Drug | maltoheptose | 1.80e-08 | 40 | 171 | 7 | CID003037125 | |
| Drug | Panose B | 1.98e-08 | 24 | 171 | 6 | CID000439297 | |
| Drug | CID439354 | 2.59e-08 | 25 | 171 | 6 | CID000439354 | |
| Drug | methyl 1'-epiacarviosin | 2.76e-08 | 13 | 171 | 5 | CID000197426 | |
| Drug | isoacarbose | 2.76e-08 | 13 | 171 | 5 | CID000449165 | |
| Drug | dibromopropanol | 2.76e-08 | 13 | 171 | 5 | CID000007281 | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Up 200; 6.2uM; PC3; HT_HG-U133A | ACTN2 AQP3 LDAH RHO SLC22A1 ARHGAP44 AGFG2 ALOXE3 PLCD1 THNSL2 MCF2L PATJ | 2.81e-08 | 194 | 171 | 12 | 5791_UP |
| Drug | Cyclodextrins | 4.27e-08 | 14 | 171 | 5 | CID000024238 | |
| Drug | 2-chloro-4-nitrophenol | 4.27e-08 | 14 | 171 | 5 | CID000012074 | |
| Drug | terephthaloyl chloride | 4.27e-08 | 14 | 171 | 5 | CID000007488 | |
| Drug | 2-amino-6-picoline | 4.55e-08 | 6 | 171 | 4 | CID000015765 | |
| Drug | phenol blue | 4.55e-08 | 6 | 171 | 4 | CID000075078 | |
| Drug | Gu-4 | 4.55e-08 | 6 | 171 | 4 | CID000448679 | |
| Drug | Borane dimethylamine complex | 4.55e-08 | 6 | 171 | 4 | CID009898794 | |
| Drug | AC1L3OV4 | 4.55e-08 | 6 | 171 | 4 | CID000092801 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 4.55e-08 | 6 | 171 | 4 | CID009577343 | |
| Drug | AC1OAGH8 | 4.55e-08 | 6 | 171 | 4 | CID006857368 | |
| Drug | vermella | 4.55e-08 | 6 | 171 | 4 | CID000203726 | |
| Drug | hymenin | 4.55e-08 | 6 | 171 | 4 | CID000010499 | |
| Drug | mercuric thiocyanate | 4.55e-08 | 6 | 171 | 4 | CID000011615 | |
| Drug | 4-nitrophenylmaltoheptaoside | 6.37e-08 | 15 | 171 | 5 | CID000173254 | |
| Drug | gamma-cyclodextrin | 9.21e-08 | 16 | 171 | 5 | CID000086575 | |
| Drug | Bay e 4609 | 9.21e-08 | 16 | 171 | 5 | CID003085308 | |
| Drug | methyl blue | 1.06e-07 | 7 | 171 | 4 | CID011969534 | |
| Drug | 3KBG5CNP | 1.06e-07 | 7 | 171 | 4 | CID003083250 | |
| Drug | AC1L9UU3 | 1.06e-07 | 7 | 171 | 4 | CID000071762 | |
| Drug | Paramax | 1.06e-07 | 7 | 171 | 4 | CID000156411 | |
| Drug | amino-methyl | 1.06e-07 | 7 | 171 | 4 | CID000142005 | |
| Drug | Alfadexum | 1.57e-07 | 54 | 171 | 7 | CID000024796 | |
| Drug | Tony Red | 1.78e-07 | 18 | 171 | 5 | CID005379348 | |
| Drug | trimitan | 1.78e-07 | 18 | 171 | 5 | CID000005561 | |
| Drug | aprophen | 1.78e-07 | 18 | 171 | 5 | CID000071128 | |
| Drug | boric acid gel | 2.10e-07 | 8 | 171 | 4 | CID003016474 | |
| Drug | AC1NSVJM | 2.10e-07 | 8 | 171 | 4 | CID005317411 | |
| Drug | N-vinylcaprolactam | 2.10e-07 | 8 | 171 | 4 | CID000075227 | |
| Drug | 9-azidoacridine | 2.10e-07 | 8 | 171 | 4 | CID000146692 | |
| Drug | acrinor | 2.10e-07 | 8 | 171 | 4 | CID005489637 | |
| Drug | NSC300622 | 2.10e-07 | 8 | 171 | 4 | CID000028426 | |
| Drug | theodrenaline | 2.10e-07 | 8 | 171 | 4 | CID000071857 | |
| Drug | rhodanile blue | 2.10e-07 | 8 | 171 | 4 | CID000073372 | |
| Drug | PNPC | 2.23e-07 | 35 | 171 | 6 | CID000165125 | |
| Drug | validoxylamine A | 2.41e-07 | 19 | 171 | 5 | CID000161975 | |
| Drug | BCDs | 3.15e-07 | 37 | 171 | 6 | CID000364214 | |
| Drug | cellobiitol | 3.15e-07 | 37 | 171 | 6 | CID000003871 | |
| Drug | pg 6 | 3.19e-07 | 20 | 171 | 5 | CID000070931 | |
| Drug | GSAD | 3.76e-07 | 9 | 171 | 4 | CID009909127 | |
| Drug | GU-3 | 3.76e-07 | 9 | 171 | 4 | CID000448687 | |
| Drug | zingiberene | 3.76e-07 | 9 | 171 | 4 | CID000092776 | |
| Drug | Atonik | 3.76e-07 | 9 | 171 | 4 | CID000069471 | |
| Drug | H 187 | 3.76e-07 | 9 | 171 | 4 | CID000001742 | |
| Drug | mercuric nitrate | 3.76e-07 | 9 | 171 | 4 | CID000024864 | |
| Drug | AC1L3XPY | 4.16e-07 | 21 | 171 | 5 | CID000124005 | |
| Drug | AC1N3UXZ | 4.16e-07 | 3 | 171 | 3 | CID004118625 | |
| Drug | maltohexaose | 4.37e-07 | 39 | 171 | 6 | CID000439606 | |
| Drug | Sudan black B | 5.16e-07 | 64 | 171 | 7 | CID000061336 | |
| Drug | maltosaccharide | 5.35e-07 | 22 | 171 | 5 | CID005461034 | |
| Drug | I ZE | 6.23e-07 | 10 | 171 | 4 | CID009549200 | |
| Drug | trans-cinnamamide | 6.23e-07 | 10 | 171 | 4 | CID000012135 | |
| Drug | CG-120 | 6.23e-07 | 10 | 171 | 4 | CID000171403 | |
| Drug | eicosa-11,14-dienoic acid | 6.23e-07 | 10 | 171 | 4 | CID000003208 | |
| Drug | UDP-pyridoxal | 6.23e-07 | 10 | 171 | 4 | CID000126789 | |
| Drug | naphthalene-1,3,6,8-tetrol | 6.23e-07 | 10 | 171 | 4 | CID000440202 | |
| Disease | alpha-amylase 1 measurement | 1.28e-07 | 9 | 169 | 4 | EFO_0801371 | |
| Disease | Prostatic Neoplasms | COL15A1 ABO SRD5A2 GPX3 IDH1 LDAH ZIC2 NDRG1 PIK3R2 TPP1 UGT2B15 UGT2B17 ALOXE3 PATJ | 1.36e-05 | 616 | 169 | 14 | C0033578 |
| Disease | Malignant neoplasm of prostate | COL15A1 ABO SRD5A2 GPX3 IDH1 LDAH ZIC2 NDRG1 PIK3R2 TPP1 UGT2B15 UGT2B17 ALOXE3 PATJ | 1.36e-05 | 616 | 169 | 14 | C0376358 |
| Disease | spina bifida (is_marker_for) | 3.26e-05 | 2 | 169 | 2 | DOID:0080016 (is_marker_for) | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 3.91e-05 | 12 | 169 | 3 | EFO_0800291 | |
| Disease | free cholesterol to total lipids in large VLDL percentage | 5.92e-05 | 37 | 169 | 4 | EFO_0022281 | |
| Disease | cholic acid glucuronide measurement | 9.75e-05 | 3 | 169 | 2 | EFO_0800574 | |
| Disease | nevoid basal cell carcinoma syndrome (is_marker_for) | 9.75e-05 | 3 | 169 | 2 | DOID:2512 (is_marker_for) | |
| Disease | lipoprotein measurement, phospholipid measurement | 1.32e-04 | 85 | 169 | 5 | EFO_0004639, EFO_0004732 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 1.41e-04 | 18 | 169 | 3 | EFO_0800288 | |
| Disease | etiocholanolone glucuronide measurement | 1.67e-04 | 19 | 169 | 3 | EFO_0800362 | |
| Disease | microphthalmia (is_implicated_in) | 1.94e-04 | 4 | 169 | 2 | DOID:10629 (is_implicated_in) | |
| Disease | X-25937 measurement | 1.94e-04 | 4 | 169 | 2 | EFO_0800937 | |
| Disease | colorectal adenoma (is_marker_for) | 1.96e-04 | 20 | 169 | 3 | DOID:0050860 (is_marker_for) | |
| Disease | androsterone glucuronide measurement | 1.96e-04 | 20 | 169 | 3 | EFO_0800317 | |
| Disease | Disorder of eye | 2.31e-04 | 212 | 169 | 7 | C0015397 | |
| Disease | free androgen index | 3.23e-04 | 374 | 169 | 9 | EFO_0007005 | |
| Disease | cholesterol to total lipids in IDL percentage | 3.94e-04 | 60 | 169 | 4 | EFO_0022233 | |
| Disease | chylomicron measurement, very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 4.20e-04 | 61 | 169 | 4 | EFO_0008317, EFO_0008596, EFO_0020946 | |
| Disease | high density lipoprotein particle size measurement | 4.57e-04 | 170 | 169 | 6 | EFO_0008592 | |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | 5.52e-04 | 321 | 169 | 8 | EFO_0004612, EFO_0004639 | |
| Disease | glycoprotein measurement | 6.27e-04 | 119 | 169 | 5 | EFO_0004555 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | 6.61e-04 | 330 | 169 | 8 | EFO_0004529, EFO_0004612 | |
| Disease | X-24574 measurement | 6.72e-04 | 7 | 169 | 2 | EFO_0800897 | |
| Disease | heart failure | 7.12e-04 | 185 | 169 | 6 | EFO_0003144 | |
| Disease | aspartate aminotransferase measurement | ABO GALNT2 SRD5A2 MUC19 NUP214 PTCH1 POM121C GLI1 SLC22A1 SCARB1 MMP15 PRRC2A MTARC1 MOV10 | 7.41e-04 | 904 | 169 | 14 | EFO_0004736 |
| Disease | non-high density lipoprotein cholesterol measurement | ABO GALNT2 DPP3 ZFPM1 NFIA SLC22A1 SCARB1 UGT2B15 UGT2B17 THNSL2 HYDIN MTARC1 | 8.74e-04 | 713 | 169 | 12 | EFO_0005689 |
| Disease | joint hypermobility measurement | 8.87e-04 | 33 | 169 | 3 | EFO_0007905 | |
| Disease | restless legs syndrome (implicated_via_orthology) | 8.93e-04 | 8 | 169 | 2 | DOID:0050425 (implicated_via_orthology) | |
| Disease | basal cell carcinoma (is_marker_for) | 8.93e-04 | 8 | 169 | 2 | DOID:2513 (is_marker_for) | |
| Disease | deoxycholic acid glucuronide measurement | 8.93e-04 | 8 | 169 | 2 | EFO_0800575 | |
| Disease | holoprosencephaly (is_implicated_in) | 8.93e-04 | 8 | 169 | 2 | DOID:4621 (is_implicated_in) | |
| Disease | basal cell adhesion molecule measurement | 8.93e-04 | 8 | 169 | 2 | EFO_0008032 | |
| Disease | circulating alpha-Klotho measurement | 8.93e-04 | 8 | 169 | 2 | EFO_0020102 | |
| Disease | choline measurement | 9.34e-04 | 130 | 169 | 5 | EFO_0010116 | |
| Disease | COVID-19 symptoms measurement | 1.06e-03 | 35 | 169 | 3 | EFO_0600019 | |
| Disease | Neuronal ceroid lipofuscinosis | 1.14e-03 | 9 | 169 | 2 | cv:C0027877 | |
| Disease | aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement | 1.24e-03 | 364 | 169 | 8 | EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946 | |
| Disease | phospholipid measurement | 1.30e-03 | 140 | 169 | 5 | EFO_0004639 | |
| Disease | dipeptidase 2 measurement | 1.42e-03 | 10 | 169 | 2 | EFO_0801528 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.42e-03 | 10 | 169 | 2 | EFO_0022090 | |
| Disease | Holoprosencephaly sequence | 1.42e-03 | 10 | 169 | 2 | cv:C0079541 | |
| Disease | serum alanine aminotransferase measurement | COL12A1 ABO SRD5A2 LAMA5 PTCH1 POM121C NRXN2 PIK3R2 NUP210 PATJ MMP15 MTARC1 OR2H2 | 1.56e-03 | 869 | 169 | 13 | EFO_0004735 |
| Disease | retinitis pigmentosa (is_implicated_in) | 1.68e-03 | 41 | 169 | 3 | DOID:10584 (is_implicated_in) | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.73e-03 | 11 | 169 | 2 | EFO_0801531 | |
| Disease | pulmonary fibrosis | 1.73e-03 | 11 | 169 | 2 | EFO_0009448 | |
| Disease | aortic stenosis, aortic valve calcification | 1.80e-03 | 42 | 169 | 3 | EFO_0000266, EFO_0005239 | |
| Disease | phospholipids:total lipids ratio, high density lipoprotein cholesterol measurement | 2.03e-03 | 307 | 169 | 7 | EFO_0004612, EFO_0020946 | |
| Disease | gallbladder carcinoma (is_marker_for) | 2.07e-03 | 12 | 169 | 2 | DOID:4948 (is_marker_for) | |
| Disease | alkaline phosphatase measurement | ABO SRD5A2 ZFPM1 PTCH1 TXNDC11 NFATC3 SLC22A1 EXOC3L4 GLIS2 UGT2B15 UGT2B17 THNSL2 STARD3NL MTARC1 | 2.20e-03 | 1015 | 169 | 14 | EFO_0004533 |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.34e-03 | 315 | 169 | 7 | EFO_0004612, EFO_0008591 | |
| Disease | peak expiratory flow | 2.39e-03 | 498 | 169 | 9 | EFO_0009718 | |
| Disease | X-11444 measurement | 2.44e-03 | 13 | 169 | 2 | EFO_0021237 | |
| Disease | pulmonary emphysema (implicated_via_orthology) | 2.44e-03 | 13 | 169 | 2 | DOID:9675 (implicated_via_orthology) | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 2.44e-03 | 13 | 169 | 2 | EFO_0800293 | |
| Disease | X-19141 measurement | 2.44e-03 | 13 | 169 | 2 | EFO_0800799 | |
| Disease | total lipids in small LDL | 2.49e-03 | 47 | 169 | 3 | EFO_0022168 | |
| Disease | Gastrointestinal Stromal Sarcoma | 2.49e-03 | 47 | 169 | 3 | C3179349 | |
| Disease | myopathy (implicated_via_orthology) | 2.64e-03 | 48 | 169 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Liver carcinoma | 2.70e-03 | 507 | 169 | 9 | C2239176 | |
| Disease | apolipoprotein B to apolipoprotein A1 ratio | 2.80e-03 | 49 | 169 | 3 | EFO_0021897 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 2.84e-03 | 14 | 169 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | glucose-dependent insulinotropic peptide measurement, glucose tolerance test | 2.84e-03 | 14 | 169 | 2 | EFO_0004307, EFO_0008464 | |
| Disease | early cardiac repolarization measurement | 2.84e-03 | 14 | 169 | 2 | EFO_0004885 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 2.84e-03 | 14 | 169 | 2 | EFO_0800283 | |
| Disease | Gastrointestinal Stromal Tumors | 2.97e-03 | 50 | 169 | 3 | C0238198 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 2.97e-03 | 50 | 169 | 3 | EFO_0022334 | |
| Disease | triglycerides to total lipids in large LDL percentage | 3.14e-03 | 51 | 169 | 3 | EFO_0022331 | |
| Disease | lipoprotein measurement | 3.17e-03 | 105 | 169 | 4 | EFO_0004732 | |
| Disease | Alobar Holoprosencephaly | 3.26e-03 | 15 | 169 | 2 | C0431363 | |
| Disease | triglycerides to total lipids in chylomicrons and extremely large VLDL percentage | 3.26e-03 | 15 | 169 | 2 | EFO_0022328 | |
| Disease | phospholipids in IDL measurement | 3.32e-03 | 52 | 169 | 3 | EFO_0022164 | |
| Disease | apolipoprotein A 1 measurement, apolipoprotein B measurement | 3.39e-03 | 107 | 169 | 4 | EFO_0004614, EFO_0004615 | |
| Disease | platelet crit | ABO GALNT2 CXXC5 LAMA5 MECOM ZFPM1 EHD4 MSI2 EOMES NFIA EXOC3L4 UBE2Z MOV10 | 3.42e-03 | 952 | 169 | 13 | EFO_0007985 |
| Disease | Lobar Holoprosencephaly | 3.71e-03 | 16 | 169 | 2 | C0431362 | |
| Disease | Semilobar Holoprosencephaly | 3.71e-03 | 16 | 169 | 2 | C0751617 | |
| Disease | Ciliopathies | 3.74e-03 | 110 | 169 | 4 | C4277690 | |
| Disease | fatty acid measurement | 3.78e-03 | 436 | 169 | 8 | EFO_0005110 | |
| Disease | coronary artery disease, factor VII measurement | 3.87e-03 | 111 | 169 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | factor VIII measurement, coronary artery disease | 4.12e-03 | 113 | 169 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | Holoprosencephaly | 4.19e-03 | 17 | 169 | 2 | C0079541 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 4.19e-03 | 17 | 169 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | cholesterol to total lipids in chylomicrons and extremely large VLDL percentage | 4.19e-03 | 17 | 169 | 2 | EFO_0022232 | |
| Disease | low density lipoprotein cholesterol measurement, lipid measurement | 4.25e-03 | 114 | 169 | 4 | EFO_0004529, EFO_0004611 | |
| Disease | total cholesterol measurement, low density lipoprotein cholesterol measurement | 4.25e-03 | 114 | 169 | 4 | EFO_0004574, EFO_0004611 | |
| Disease | idiopathic pulmonary fibrosis | 4.30e-03 | 57 | 169 | 3 | EFO_0000768 | |
| Disease | Intellectual Disability | 4.38e-03 | 447 | 169 | 8 | C3714756 | |
| Disease | cholesterol in IDL measurement | 4.52e-03 | 58 | 169 | 3 | EFO_0021899 | |
| Disease | total lipids in medium HDL measurement | 4.52e-03 | 58 | 169 | 3 | EFO_0022310 | |
| Disease | free cholesterol in medium HDL measurement | 4.52e-03 | 58 | 169 | 3 | EFO_0022267 | |
| Disease | triacylglycerol 56:3 measurement | 4.70e-03 | 18 | 169 | 2 | EFO_0010430 | |
| Disease | Hemangiosarcoma | 4.70e-03 | 18 | 169 | 2 | C0018923 | |
| Disease | sexual dimorphism measurement | ABO GALNT2 GPX5 CXXC5 POM121L2 PTCH1 ADAMTSL3 CITED4 ACAN SCARB1 SEC16A STARD3NL PATJ MTARC1 | 4.71e-03 | 1106 | 169 | 14 | EFO_0021796 |
| Disease | cholesterol in medium HDL measurement | 4.74e-03 | 59 | 169 | 3 | EFO_0021903 | |
| Disease | asthma (biomarker_via_orthology) | 4.74e-03 | 59 | 169 | 3 | DOID:2841 (biomarker_via_orthology) | |
| Disease | spine bone mineral density | 4.95e-03 | 119 | 169 | 4 | EFO_0007701 | |
| Disease | phospholipids in small VLDL measurement | 4.97e-03 | 60 | 169 | 3 | EFO_0022146 | |
| Disease | total lipids in IDL | 4.97e-03 | 60 | 169 | 3 | EFO_0022161 | |
| Disease | free cholesterol to total lipids in medium HDL percentage | 4.97e-03 | 60 | 169 | 3 | EFO_0022282 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipid measurement | 5.10e-03 | 120 | 169 | 4 | EFO_0004611, EFO_0004639 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GAVPVAGFFLYPQTQ | 201 | Q9UKU6 | |
| SGLGFPPQLFTGCVY | 101 | Q6ZRU5 | |
| NVYGSPDFLGAPGLA | 346 | Q17RC7 | |
| PGGRYGVQSFFPEPF | 466 | O95936 | |
| NVEYFGLGNSPGFPL | 226 | P05026 | |
| GPGSVPGALDYAAFS | 871 | P35609 | |
| AVDPPGSYRAGGTVF | 541 | Q6UY14 | |
| LLSPVGPYFSSGTFN | 186 | P54687 | |
| TPLFGTLHPGFYGSS | 226 | P16442 | |
| PEGTVPLYSGFSFLF | 1461 | Q01955 | |
| AFTGGPPAGNFAAEY | 86 | H3BNL8 | |
| YVRPGGGFVPNFQLF | 121 | P22352 | |
| GSYFNPGSRDFPAVP | 131 | P0DTE7 | |
| GSYFNPGSRDFPAVP | 131 | P0DTE8 | |
| GSYFNPGSRDFPAVP | 131 | P0DUB6 | |
| SFFSAPEGYDHPLGG | 181 | Q9H9G7 | |
| GSYFNPGSRDFPAVP | 131 | P19961 | |
| FPQGPSTDGFFLHVG | 691 | Q5T5Y3 | |
| PYPFSGIFEISPGNA | 46 | Q9BSY9 | |
| SGLEDPTFGYSTGQP | 231 | Q9UN42 | |
| PGPSGGDFDTYSNIR | 2331 | Q9HC84 | |
| DSPGEEPFYTGQGRS | 286 | Q12857 | |
| GNTPFLFPLYGQGEI | 371 | P26374 | |
| FPGFPAAAYGPVAAA | 241 | Q96DH6 | |
| EDGFVGALDLFPPGY | 471 | Q92698 | |
| GPNFYVPFSNATGVV | 6 | P08100 | |
| GVPGQVDFYARFSPS | 41 | Q15118 | |
| EEPTPGLGNFAFYNS | 286 | Q0D2K2 | |
| GFSFSFPGLFPSGLY | 486 | Q03112 | |
| GVGTPFSYAVPGQAN | 266 | Q15818 | |
| YFGTIGIGTPAQDFT | 76 | P0DJD9 | |
| SEGTGFFPGNYVEPS | 351 | Q9P2A4 | |
| GSYFNPGSRDFPAVP | 131 | P04746 | |
| GLLSGPRGFFSSPNY | 146 | Q9BY79 | |
| PFTGFFYALEGSTQP | 311 | Q9H2M9 | |
| GPGPYGASLFQHFLD | 1791 | Q8TEM1 | |
| PGTPQLEFSAFGAFG | 431 | Q8IVT2 | |
| FFVPENFPGYGEIGV | 646 | Q8N6Y1 | |
| GNGSALDAFTYGPSP | 66 | Q6ISU1 | |
| FFGLFYAVGTPSLNP | 271 | O95918 | |
| GRVGVFPSNYVAPGA | 66 | Q02779 | |
| SPLFGQYFVLENPGT | 311 | Q5VT66 | |
| TYFLQAGEASGAPPA | 31 | Q9BY89 | |
| TTPSGGGFFQGISFP | 211 | P42166 | |
| SYTFPPSDDTFLGGN | 191 | P46934 | |
| GFAELYGSNGPQSFT | 1256 | P46934 | |
| QVDYAAFGEPGPFPA | 151 | Q9GZZ0 | |
| DSSGPVIFDPASFYG | 226 | Q9HA64 | |
| DPALYGGVQAAFPGA | 281 | Q5IJ48 | |
| GAPSYGAAGLAFPAQ | 186 | P05412 | |
| DQGDSSGNRYLPGFP | 181 | Q9BYJ1 | |
| NKGYLPGQGPFVAAF | 331 | Q9NR71 | |
| PFDGTGGFLAHAYFP | 211 | P51511 | |
| FGNASGFYISTPTGP | 386 | P98073 | |
| PYTFPGGSGTVFARN | 366 | Q10471 | |
| AGANGPFPHEYVSGT | 1416 | O75197 | |
| GDSVNTPQAGYFGLF | 51 | Q8TAF8 | |
| FGNTGNISGAPVTYP | 766 | Q86XP3 | |
| FGFVNLGPIFPDGQY | 56 | Q6UW60 | |
| KSEDTPPGGFFYGSS | 131 | Q7Z5P9 | |
| APGQQDGAASFPAGY | 96 | Q92597 | |
| PFTPGDYDVNITFGG | 1411 | Q14315 | |
| AGALFLPQYVFGPDA | 521 | Q8IX07 | |
| FFYIGGSPNTADLPG | 426 | Q9P2S2 | |
| ITATFYFPVGPGTGF | 56 | Q9BUN8 | |
| APEAFYAGSRGGPSV | 401 | Q86XN8 | |
| AFSPEGQPIGGYTET | 336 | Q99687 | |
| FSPSGTGFNFGIITP | 1216 | P35658 | |
| FAGSGIPAGINIPNY | 381 | Q9NY33 | |
| EPGELIPNGPFSFYG | 266 | P48742 | |
| GGGQNFDPYLPTSVY | 671 | P08151 | |
| AFDGTTEGPFNQGYG | 416 | Q9H223 | |
| PPTFSAFNEDYVGSG | 121 | Q9Y2C4 | |
| GDPRIFQGYSFVAPS | 351 | O75676 | |
| SYPAPGINGGDFDTF | 1591 | P98088 | |
| PGLSYSGSFFIQAVP | 181 | Q05215 | |
| VPSSFQFFLPLGSGG | 126 | Q9BZE0 | |
| REEAGGGFSLHPPYF | 36 | O15230 | |
| GGFSLHPPYFNLAEG | 41 | O15230 | |
| TSGTGGFNFGAPFQP | 36 | P37198 | |
| LYLVDGGFAINSPFP | 676 | Q68DD2 | |
| AGIENYTSRFGPGSP | 251 | Q969F2 | |
| ALNGQSDFPYLGAFP | 201 | Q7LFL8 | |
| GGAFFNFADGAPSAP | 126 | Q5XG87 | |
| GEPPGTPYFSGDFAS | 1996 | P16112 | |
| YFGTIGIGTPAQDFT | 76 | P0DJD8 | |
| FYNGLSFSSSPGPVG | 731 | Q14671 | |
| FVGVGPFGSAAPSFS | 1191 | A8CG34 | |
| GFSSPGTPGQAFYEM | 506 | P51178 | |
| APGGNSGNPIYDFFL | 161 | O76062 | |
| PTFYPFLTGVGATQD | 401 | P58401 | |
| QRGDFPGTYVEFLGP | 66 | O00459 | |
| PGVQFYTGNFLDGTL | 276 | Q96C23 | |
| FEGLSPTVYSNPEGF | 21 | Q4VC39 | |
| GDQYRATDFVVPGPG | 136 | O75874 | |
| FTVYPGFGSIPSGGQ | 3266 | Q4G0P3 | |
| YFSGPGTPLTGNAAT | 796 | Q99715 | |
| FSSAVLGEGPNNGYF | 266 | Q9UKA2 | |
| PIYGFGFVAGSERPV | 61 | Q5JV73 | |
| QHPFGSVPFGYGVRA | 461 | Q02318 | |
| VQSFYTPRSNPGGFG | 221 | Q7Z7K6 | |
| APAYVASGPFREAGF | 116 | Q8NI60 | |
| GPFYFILGADPQFGL | 31 | Q9BRF8 | |
| GRGQDGSPVITFPDY | 86 | O15068 | |
| VFGRLASPGFPGEYA | 26 | O00187 | |
| TFIPGQGNNAYVFPG | 481 | Q16798 | |
| PGGFSFEASGPGNFF | 476 | Q99615 | |
| PYGVTAVDFSIGAPN | 536 | Q5VTH9 | |
| PEAAGLFQGTFPDGF | 51 | Q9UEF7 | |
| DQVFFYLPVGQGPSS | 261 | P35212 | |
| YVRPGGGFVPSFQLF | 121 | O75715 | |
| VIPQDQSFGPGYAGI | 116 | O14815 | |
| LPSSVSFVTGYGGFP | 51 | P39059 | |
| QPGLYFGGAAAVAEP | 31 | Q9UNI6 | |
| NYTVPGLGPAGEAFL | 71 | O15245 | |
| TGGEELFGLPATQYP | 1386 | Q8TE73 | |
| YFGTIGIGTPAQDFT | 76 | P0DJD7 | |
| FSPEGQPIGGYTETE | 236 | A6NDR6 | |
| FGASRDYFPPGDFPG | 1336 | Q96PC5 | |
| FFGLFYAVGTPSLNP | 271 | Q9GZK4 | |
| YLGLFSGSSPNPFSE | 21 | Q6NUM9 | |
| GPGLFEVGSEPFYHL | 46 | Q16518 | |
| LVAPPFGGILYEFAG | 226 | Q16572 | |
| NFAFSGGLYGGLPPT | 256 | Q12972 | |
| SFGTPAPGFSSMLYG | 46 | Q9HCE1 | |
| PLGGFPHYGEVNNDF | 316 | Q92901 | |
| GPLSFGFALGYSSPA | 36 | Q9NY64 | |
| YAVGPAQSPPTFGFL | 36 | Q9BXW7 | |
| SGYTFPAGVSVPGTF | 681 | Q92540 | |
| FYSTPLQPGGQSGFL | 1956 | P48634 | |
| SFFGPYPEVSPANGL | 1176 | Q13635 | |
| IPEYVPAFANTGGGY | 231 | Q7Z7L1 | |
| TLFANGSIYPPNEGF | 306 | Q8WTV0 | |
| PRVNFEGALFSGYAP | 11 | Q86YJ6 | |
| FAIGYEFSPGPDEGV | 2141 | O75592 | |
| FTFYDGPPFATGLPH | 41 | P41252 | |
| FGFAGTPGYLSPEVL | 171 | Q9UQM7 | |
| VKTTYAPGFPAGAQG | 631 | E7EW31 | |
| PGEIEFNITGNYGSP | 446 | Q17R89 | |
| FGSRAPQPFTFGGFV | 881 | Q96KW2 | |
| GGYVIKASEGPAFFP | 531 | Q9NSD9 | |
| DYFEFAGGSAPGTSP | 86 | Q86UE8 | |
| FPAFGGQTPSQGGFA | 246 | O95081 | |
| FVSGPNGTAGIFATY | 136 | Q92482 | |
| ALAYGAFGPPSSFQP | 61 | Q96RK1 | |
| PTYLGNETSVFGPTG | 266 | O75503 | |
| FYIPGTEFSLGPDLG | 1696 | Q86UP3 | |
| ASFIGGQFLPYFIPG | 3206 | Q86UP3 | |
| GGFDSPFYRDSLPGS | 501 | Q92574 | |
| RAPTFSYGPDGNGFS | 246 | Q5W0Z9 | |
| QPGGYPATGADVAFS | 36 | O95070 | |
| SGSLYGFFGEPTRPA | 616 | Q7RTX1 | |
| SSPGPVGFEDSYGQE | 571 | P60852 | |
| GGVFFLDITFSPDYP | 101 | Q96LR5 | |
| GTYRSNFSSGPGFPE | 1406 | O15027 | |
| FTGYGGFQAPLSVDP | 1411 | Q8NI35 | |
| GGLSDGQFYSPPESE | 201 | O95772 | |
| ASEGGLFGPAPDLYF | 176 | Q9P253 | |
| SFSDPFTGGGRYVPG | 466 | Q9Y263 | |
| ADPFTGAGRYVPGSA | 491 | Q9Y263 | |
| HGGSGLGPAVFPFQY | 316 | Q12968 | |
| PQGGLFTYVSGANFL | 181 | P31213 | |
| TGPFDTPYEGGFFLF | 136 | Q9H832 | |
| VLGYFEFSGSPQPPG | 236 | Q6PKC3 | |
| EFSGSPQPPGYLTFF | 241 | Q6PKC3 | |
| GPQYPAIGVTTFGAS | 6 | Q15915 | |
| FEKNGGGFLFPPSYV | 181 | P54855 | |
| DFFPGLGYGEAIPAF | 366 | Q2TAA8 | |
| PPGSVYEGGVFFLDI | 86 | P51965 | |
| FLPYRAEVGPAGSQF | 711 | Q6PJF5 | |
| HSTRPGPFFYIGGSN | 151 | Q6ZVT0 | |
| VEKNGGGFLFPPSYV | 181 | O75795 | |
| DPNVTGVFLGPYPFG | 501 | Q13488 | |
| AFTSQGPGAYPGSAA | 76 | O95409 | |
| YISGGGFSNVFPRPS | 406 | O14773 | |
| PERAFPSGGAVYGAQ | 376 | Q9H5J0 | |
| GAYFLPEFALSPQGS | 31 | P82987 | |
| IFPIGFYINEVGGQP | 116 | Q8NHV5 | |
| PGNPGFSAFYVPFAK | 51 | Q9H6V9 | |
| LLNFIGQGPATYGPF | 1151 | Q6PIF6 |